Unknown

Dataset Information

0

VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People.


ABSTRACT: Alaska Native and American Indian (AN/AI) people have unique pharmacogene variation that may affect warfarin disposition and therapeutic response. We performed targeted genotyping for cytochrome P450 (CYP)2C9, vitamin K epoxide oxidase reductase complex subunit 1 (VKORC1), CYP4F2, CYP4F11, and gamma-glutamyl carboxylase (GGCX) variants in AN/AI people receiving warfarin. The primary outcome was stable warfarin dose, defined as one dose, and associated international normalized ratio within the target range, at least 6 months after starting therapy, with two matching doses at least 2 weeks apart. Genotype-phenotype relationships were assessed by multivariate regression analysis, adjusted for self-reported heritage, age, gender, and concurrent statin use. VKORC1 genotype explained 34% of dose variability, with VKORC1 -1639G>A and 1173C>T associated with a 1.7 mg/day (P = 1.4e-05) dose reduction. Additionally, CYP2C9 N218I was suggestively significant (P = 0.077), with heterozygotes requiring 1.1 mg/day less than reference individuals. Self-reported heritage was significantly associated with dose, largely driven by differences in the diagnostic VKORC1 allele frequencies among AN/AI people.

SUBMITTER: Henderson LM 

PROVIDER: S-EPMC6510382 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications


Alaska Native and American Indian (AN/AI) people have unique pharmacogene variation that may affect warfarin disposition and therapeutic response. We performed targeted genotyping for cytochrome P450 (CYP)2C9, vitamin K epoxide oxidase reductase complex subunit 1 (VKORC1), CYP4F2, CYP4F11, and gamma-glutamyl carboxylase (GGCX) variants in AN/AI people receiving warfarin. The primary outcome was stable warfarin dose, defined as one dose, and associated international normalized ratio within the ta  ...[more]

Similar Datasets

| S-EPMC4461509 | biostudies-literature
| S-EPMC5944577 | biostudies-literature
| S-EPMC3292047 | biostudies-literature
| S-EPMC3718044 | biostudies-literature
| S-EPMC10499114 | biostudies-literature
| S-EPMC8301563 | biostudies-literature
| S-EPMC7364379 | biostudies-literature
| S-EPMC5384860 | biostudies-literature
| S-EPMC7249913 | biostudies-literature
| S-EPMC4744487 | biostudies-literature